Mark G. Lewis
country of citizenship: United States of America
languages spoken, written or signed: English
educated at: Ohio State University
occupation: researcher, chief executive officer, virologist, medical researcher
Articles 105
-
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
-
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
-
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
-
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
-
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
-
Animal models for COVID-19
-
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
-
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth
-
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
-
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
-
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
-
Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
-
Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines
-
Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques
-
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
-
Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus Monkeys.
-
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors.
-
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy.
-
Zika convalescent macaques display delayed induction of anmanestic cross-neutralizing antibody responses after dengue infection.
-
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
-
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
-
Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6 germinal center B cells or Bcl6 Bcl2 non-germinal center B cells
-
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy
-
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
-
Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys
-
Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques
-
Corrigendum: Zika viral dynamics and shedding in rhesus and cynomolgus macaques
-
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.
-
Zika viral dynamics and shedding in rhesus and cynomolgus macaques
-
Rapid development of a DNA vaccine for Zika virus
-
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
-
Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys
Human - wd:Q66732036